Skip to main content
OpenTrials

Clinical trial condition

Purpura, Thrombotic Thrombocytopenic

Explore clinical trials studying Purpura, Thrombotic Thrombocytopenic. Study availability and eligibility vary by location and protocol.

39 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Purpura, Thrombotic Thrombocytopenic trial results

Completed

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura

NCT02553317

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Investigator Site Birmingham, Alabama, United States
  • Investigator Site Los Angeles, California, United States
  • Investigator Site Atlanta, Georgia, United States
  • Investigator Site Boston, Massachusetts, United States
View all 101 locations
View Trial Details
Completed

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

NCT01151423

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Investigator Site Los Angeles, California, United States
  • Investigator Site Washington D.C., District of Columbia, United States
  • Investigator Site Atlanta, Georgia, United States
  • Investigator Site St Louis, Missouri, United States
View all 51 locations
View Trial Details
Completed

Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

NCT03922308

Conditions
Acquired Thrombotic Thrombocytopenic Purpura (aTTP), Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View all 24 locations
View Trial Details
Completed

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

NCT02878603

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Investigator site St Louis, Missouri, United States
  • Investigator site Valhalla, New York, United States
  • Investigator Site Durham, North Carolina, United States
  • Investigator Site Columbus, Ohio, United States
View all 45 locations
View Trial Details
Completed

Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura

NCT01554514

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations
  • Emory University Atlanta, Georgia, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP]

NCT03519672

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Congenital Thrombotic Thrombocytopenic Purpura, +14 more
Locations
  • AutoCruitment Atlanta, Georgia, United States
  • Houston Methodist Research Institute Houston, Texas, United States
  • Cambridge University Hospital Cambridge, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details

Related conditions